Abstract
The aim of this study was to investigate the clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus (SLE) patients. IgG antinucleosome antibodies were detected by a qualitative enzyme immunoassay (immunodot) in the sera of SLE patients at onset of disease. The patients were divided into two groups according to the result of the antinucleosome antibodies test: positive (group A) and negative (group B). The two groups were also evaluated for clinical and biological parameters. Of 84 patients with SLE, 66 (78.6%) had antinucleosome antibodies. Among 21 patients negative for anti-double-stranded DNA (anti-dsDNA), 5 (23.8%) were antinucleosome positive. The most common initial features were haematological disorders (80.1%) and arthritis or arthralgias (79.8%). Renal disorders, observed in 59.5% of SLE patients, were more common in group A compared to group B (65 vs 38%) (p=0.04). The European Consensus Lupus Activity Measurement (ECLAM) mean score was higher in group A (6.42) than in group B (4.44) (p=0.002). Antinucleosome antibodies were positive in nearly one-fourth of SLE patients negative for anti-dsDNA. We found a correlation between antinucleosome antibodies, nephritis and SLE disease activity. Therefore, the determination of circulating antinucleosome antibodies could be a useful parameter for early diagnosis and follow-up of SLE patients.
Similar content being viewed by others
References
Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151
Mohan C, Adams S, Stanik V, Datta SK (1993) Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177:1367–1381
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251–260
Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF, Jacob L (1994) Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:1684–1688
Kramers C, Hylkema MN, Van Bruggen MC, Van de Lagemaat R, Dijkman HB, Assmann KJ et al (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94:568–577
Burlingame RW, Boey ML, Starkebaum G, Rubin RL (1994) The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184–192
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M et al (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10:541–547
Churg J, Bernstein J, Glassock RJ (1995) Lupus nephritis. In: Renal disease: classification and atlas of glomerular diseases, 2nd edn. Igaku-Shoin Medical Publishers, New York, pp 51–79
Emlen W, Holers VM, Arend WP, Kotzin B (1992) Regulation of nuclear antigen expression on the cell surface of human monocytes. J Immunol 148:3042–3048
Andreassen K, Bredholt G, Moens U, Bendiksen S, Kauric G, Rekvig OP (1999) T cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: a molecular basis for anti-DNA antibody production. Eur J Immunol 29:2715–2728
Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L et al (2000) Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 43:76–84
Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F (2000) Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 43:2307–2315
Cairns AP, McMillan SA, Crockard AD, Meenagh GK, Duffy EM, Armstrong DJ, Bell AL (2003) Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 62:272–273
Min DJ, Kim SJ, Park SH, Seo YI, Kang HJ, Kim WU et al (2002) Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 20:13–18
Benucci M, Gobbi FL, Del Rosso A, Cesaretti S, Niccoli L, Cantini F (2003) Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 32:42–45
Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687–1696
Abraham-Simon J, Rojas-Serrano J, Cabiedes J, Alcocer-Varela J (2004) Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 13:177–181
Suenaga R, Abdou NI (1996) Anti-(DNA-histone) antibodies in active lupus nephritis. J Rheumatol 23:279–284
Van Bruggen MC, Kramers C, Hylkema MN, Smeenk RJ, Berden JH (1996) Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 105:132–139
Acknowledgements
The authors wish to thank Mrs. Ben Hamed Nadia for her assistance in revising the manuscript and Mrs. El Abed Souad and Boukthir Samia for their excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haddouk, S., Ben Ayed, M., Baklouti, S. et al. Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 24, 219–222 (2005). https://doi.org/10.1007/s10067-004-1005-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-1005-5